Bionano Genomics, Inc. (BNGO) analyst actions
Rating and price-target actions on BNGO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BNGO overview →
3 measured BNGO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma | Press release | +0.00% | +1.70% | |
| Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate | Press release | +2.33% | +0.99% | |
| Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research | Press release | +1.19% | -2.37% |
Keep exploring
More BNGO: earnings → · SEC filings → · BNGO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.